ERBB2 and neoplasm: The tumor phenotypes on baseline CNB were distributed as follows: 1275 Luminal-A (22.7%), 2222 Luminal-B/HER2-Negative (39.6%), 726 Luminal-B/HER2-Positive (12.9%), 609 HER2-amplified (10.9%) and 778 TNBC (13.9%).